Given that our recent study identified monomeric CRP as a mediating factor for APOE ε4-related AD pathogenesis [48], this study suggests that CRP may also be such a mediating factor in the AD pathophysiological process related to SPI1 or CD33. The gene discussed is CD33; the disease is Alzheimer disease.